HIV/AIDS Prognosis
Immunologic factors predict long-term nonprogression in HIV-infected children
Published in AIDS Weekly, July 11th, 2005
According to recent research published in the Journal of Allergy and Clinical Immunology, "Early markers that predict immunologic long-term nonprogression in infants with perinatally acquired HIV infection might assist in subsequent antiretroviral treatment decisions. We sought to identify early markers of immunologic long-term HIV disease nonprogression."
"We analyzed immunologic and virologic characteristics at I and 2 months of age in HIV-infected children who were enrolled in the Women and Infants Transmission Study and born before 1995, comparing immunologic...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2005-07-11)
More Articles from AIDS Weekly
- HIV/AIDS & Measles
Maternal HIV infection may reduce levels of measles antibodies in newborns - HIV/AIDS Diagnostics
Cobas AmpliPrep/Cobas Amplicor HIV-1 Monitor comparable to manual method - HIV/AIDS Immunology
HIV-specific IgA can neutralize HIV replication inside cells - HIV/AIDS Prognosis
Females w/ 104-105 baseline VLs have lower risk of HIV progress than men - Advocacy
Provider of HIV/AIDS medical care lauds U.S. Rep. Henry Waxman's stand on CAFTA - Bacterial Vaginosis
Bacterio-therapeutics company receives NIH grant for bacterial vaginosis - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
